Source link : https://www.newshealth.biz/health-news/first-in-class-endometriosis-rx-given-green-light-by-mhra/
The Medicines and Healthcare Products Regulatory Agency (MHRA) has granted a licence for relugolix combination therapy (Ryeqo, Gedeon Richter) for the symptomatic treatment of endometriosis in adult women of reproductive age who have a history of previous medical or surgical treatment for endometriosis. Relugolix is a GnRH receptor antagonist that selectively binds to the gonadotrophin-releasing […]
Author : News Health
Publish date : 2024-09-04 15:06:58
Copyright for syndicated content belongs to the linked Source.